title: Cutaneous and immunologic reactions to phenytoin.
abstract: Phenytoin (diphenylhydantoin; Dilantin) is a highly effective and widely prescribed anticonvulsant and antiarrhythmic agent. Since 1938 it has been invaluable in the treatment of grand mal and psychomotor epilepsy. Hydantoin derivatives have been used medicinally for more than a half-century. In recent years dermatologists have broadened the indications for phenytoin use to include recessive dystrophic epidermolysis bullosa, linear scleroderma, and pachyonychia congenita. In spite of widespread use and popularity, it is interesting that the frequency of complications relating to drug therapy remains low, relatively speaking. Nevertheless, a broad spectrum of cutaneous and immunologic reactions to phenytoin have been reported. These range from tissue proliferative syndromes (side effects), drug hypersensitivity syndromes (allergic effects), and a possible linkage with lymphoma (idiosyncratic effects). Therapeutic and toxic reactions to this commonly prescribed drug are comprehensively reviewed, analyzed, and summarized in this monograph.
authors.affiliation: University of Rochester School of Medicine, NY.
authors.forename: A K
authors.initials: AK
authors.lastname: Silverman
authors.forename: J
authors.initials: J
authors.lastname: Fairley
authors.forename: R C
authors.initials: RC
authors.lastname: Wong
mesh_terms: D002273:Carcinogens; D003875:Drug Eruptions / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D010672:Phenytoin / Q000009:adverse effects* / Q000276:immunology; D011247:Pregnancy; D013723:Teratogens
chemical_list: D002273:Carcinogens; D013723:Teratogens; D010672:Phenytoin